|
|
Volumn 479, Issue 7373, 2011, Pages 278-
|
|
Depression drug disappoints
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLCHOLINE;
ANTIDEPRESSANT AGENT;
AZD 1446;
CP 601927;
DEXMECAMYLAMINE;
ISPRONICLINE;
MILNACIPRAN;
NICOTINIC RECEPTOR;
NICOTINIC RECEPTOR ALPHA4BETA2;
PLACEBO;
UNCLASSIFIED DRUG;
VARENICLINE;
DRUG DERIVATIVE;
MECAMYLAMINE;
ALZHEIMER DISEASE;
ANTIDEPRESSANT ACTIVITY;
ATTENTION DEFICIT DISORDER;
DEPRESSION;
DRUG APPROVAL;
DRUG RESEARCH;
DRUG TREATMENT FAILURE;
GILLES DE LA TOURETTE SYNDROME;
HAMILTON SCALE;
HUMAN;
MAJOR DEPRESSION;
NERVE CELL;
NOTE;
PRIORITY JOURNAL;
SIGNAL TRANSDUCTION;
TOBACCO DEPENDENCE;
TREATMENT RESPONSE;
PHASE 3 CLINICAL TRIAL (TOPIC);
STEREOISOMERISM;
TREATMENT FAILURE;
ANTIDEPRESSIVE AGENTS;
CLINICAL TRIALS, PHASE III AS TOPIC;
DEPRESSION;
HUMANS;
MECAMYLAMINE;
STEREOISOMERISM;
TREATMENT FAILURE;
|
|
EID: 84857196864
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/479278a Document Type: Note |
|
Times cited : (11)
|
|
References (4)
|
